Background: Late-onset sepsis is a major cause of morbidity and death in neonates. Diagnosis may be complex. Hematological markers and C-reactive protein (CRP) are regularly measured as part of sepsis screening. However, the gold standard for diagnosing sepsis is the isolation of microorganisms in a blood culture. Aim: This study aimed to compare the role of hematological parameters versus CRP as diagnostic markers for late-onset neonatal sepsis (LONS) in full-term neonates. Patients & Methods: This case-control study included 50 neonates with LONS admitted to the Neonatal Intensive Care Unit (NICU) of Suez Canal University Hospital & 50 healthy controls both groups were rigorously investigated, including anthropometric data, clinical symptoms, key biomarkers, including CBC parameters & serum CRP. Results: Among the sepsis group, 43 patients (86%) had positive blood culture results as klebsiella (32%) & mixed organisms had the highest prevalence among positive results, staph (16%) & E.coli (8%). The Sepsis group had a significantly lower mean of Hemoglobin, platelets, & Platelet lymphocytic ratio than the control group with p-value <0.05.The Sepsis group had a significantly higher mean of C-reactive protein, C-reactive protein /Mean platelet volume and C-reactive protein /Albumin than the control group as p- value <0.001. CRP had the best sensitivity (100%), whereas CRP/MPV was more specific (100%). Conclusion: CRP has very good sensitivity for the diagnosis of LONS, while in combination with MPV gave more specificity for the diagnosis of LONS
28 November 2024 in Suez Canal University Medical Journal
Background:Diabetic nephropathy is considered a main microvascular complication of diabetes mellitus (DM) that results in chronic renal failure. Fatty acid-binding protein 1 (FABP1) is expressed in renal proximal tubule cells and released into urine as a result of hypoxia triggered by decreased peritubular capillary blood flow, consequently urinary FABP1 is seen as a hopeful indicator for monitoring tubulointerstitial injury. There is increasing evidence that FABP1 plays a role in the development and progression of chronic kidney disease. Aim: This study aimed to assess the correlation of circulating plasma FABP1 level as well as its urinary level to nephropathy in patients with type 2 diabetes mellitus.Methods: Ninety patients were recruited, divided into 3 groups. They were investigated for glycemic and renal biomarkers, then FABP1 concentration was measured in their serum and urine samples. Bioinformatic analysis was done to explore the relation between FABP1 and DN. Results: The presence of DN was associated with increase in both serum and urinary FABP1. A serum FABP1 concentration of >243 ng/L was associated with DN, with a sensitivity of 93% and specificity of 90%, while urinary FABP1 concentration of >155.67 ng/L was associated with DN, with a sensitivity of 90% and specificity of 73%. Bioinformatic analysis revealed interactions between FABP1 and other kidney markers. Conclusion: This study proved that serum and urinary levels of FABP1 were significantly higher in the DN group than the normo-albuminuric groups reflecting the progression of the disease, thus they can be used as diagnostic biomarkers with significant sensitivity and specificity.